Quidel ROE 2006-2019 | QDEL

Current and historical return on equity (ROE) values for Quidel (QDEL) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Quidel ROE for the three months ending June 30, 2019 was 23.34%.
Quidel ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-06-30 $0.07B $0.51B 15.46%
2019-03-31 $0.07B $0.46B 15.82%
2018-12-31 $0.07B $0.43B 19.55%
2018-09-30 $0.04B $0.39B 11.25%
2018-06-30 $0.02B $0.37B 6.98%
2018-03-31 $0.01B $0.33B 4.44%
2017-12-31 $-0.01B $0.23B -4.10%
2017-09-30 $-0.01B $0.22B -2.81%
2017-06-30 $-0.00B $0.21B -0.48%
2017-03-31 $0.00B $0.22B 1.48%
2016-12-31 $-0.01B $0.20B -7.10%
2016-09-30 $-0.01B $0.20B -5.95%
2016-06-30 $-0.01B $0.19B -5.79%
2016-03-31 $-0.01B $0.20B -6.00%
2015-12-31 $-0.01B $0.22B -2.61%
2015-09-30 $0.00B $0.22B 0.42%
2015-06-30 $-0.00B $0.23B -1.70%
2015-03-31 $-0.00B $0.25B -0.86%
2014-12-31 $-0.01B $0.25B -3.53%
2014-09-30 $-0.01B $0.22B -6.32%
2014-06-30 $-0.01B $0.22B -5.41%
2014-03-31 $-0.01B $0.23B -3.16%
2013-12-31 $0.01B $0.22B 3.19%
2013-09-30 $0.02B $0.22B 7.02%
2013-06-30 $0.02B $0.22B 8.74%
2013-03-31 $0.02B $0.22B 8.62%
2012-12-31 $0.01B $0.20B 2.65%
2012-09-30 $-0.00B $0.19B -1.62%
2012-06-30 $-0.00B $0.18B -1.63%
2012-03-31 $-0.00B $0.19B -2.18%
2011-12-31 $0.01B $0.19B 3.83%
2011-09-30 $0.01B $0.18B 3.64%
2011-06-30 $0.00B $0.18B 0.68%
2011-03-31 $0.00B $0.18B 2.29%
2010-12-31 $-0.01B $0.11B -9.54%
2010-09-30 $0.01B $0.11B 7.59%
2010-06-30 $0.03B $0.12B 24.95%
2010-03-31 $0.03B $0.12B 28.39%
2009-12-31 $0.03B $0.13B 29.27%
2009-09-30 $0.02B $0.12B 17.12%
2009-06-30 $0.01B $0.10B 7.98%
2009-03-31 $0.01B $0.11B 6.05%
2008-12-31 $0.02B $0.12B 16.27%
2008-09-30 $0.02B $0.13B 18.42%
2008-06-30 $0.02B $0.11B 16.78%
2008-03-31 $0.02B $0.11B 16.59%
2007-12-31 $0.01B $0.11B 13.13%
2007-09-30 $0.02B $0.10B 23.53%
2007-06-30 $0.02B $0.09B 24.40%
2007-03-31 $0.02B $0.10B 22.64%
2006-12-31 $0.02B $0.10B 22.83%
2006-09-30 $0.01B $0.08B 14.77%
2006-06-30 $0.01B $0.09B 13.95%
2006-03-31 $0.01B $0.09B 16.97%
2005-12-31 $-0.01B $0.09B -11.65%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.508B $0.522B
Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia and infectious mononucleosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.355B 27.89
Medtronic (MDT) Ireland $136.463B 19.49
Stryker (SYK) United States $80.545B 27.85
Boston Scientific (BSX) United States $58.324B 28.29
Baxter (BAX) United States $43.795B 26.56
EssilorLuxottica Societe Anonyme (ESLOY) France $30.720B 0.00
Zimmer Biomet Holdings (ZBH) United States $27.744B 17.76
Coloplast (CLPBY) Denmark $26.309B 42.00
Lonza Group Ag (LZAGY) Switzerland $25.750B 0.00
Terumo (TRUMY) Japan $23.727B 27.28
Smith & Nephew SNATS (SNN) United Kingdom $19.987B 0.00
ResMed (RMD) United States $19.012B 36.26
Sunny Optical Technology (SNPTF) China $13.031B 0.00
Bio-Rad Laboratories (BIO) United States $9.510B 50.98
Canopy Growth (CGC) Canada $9.478B 0.00
Insulet (PODD) United States $9.126B 540.75
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.016B 20.92
Haemonetics (HAE) United States $6.910B 52.15
Perrigo (PRGO) Ireland $6.214B 11.45
GN STORE NORD (GNNDY) Denmark $5.897B 30.11
Aurora Cannabis (ACB) Canada $5.769B 56.70
GW Pharmaceuticals (GWPH) United Kingdom $4.612B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.587B 59.66
ICU Medical (ICUI) United States $3.452B 22.39
NuVasive (NUVA) United States $3.286B 26.19
Hutchison China MediTech (HCM) China $2.661B 0.00
Agios Pharmaceuticals (AGIO) United States $2.497B 0.00
National Vision Holdings (EYE) United States $2.260B 48.78
Cardiovascular Systems (CSII) United States $1.637B 0.00
Aphria (APHA) $1.496B 0.00
Phibro Animal Health (PAHC) United States $1.215B 18.20
AtriCure (ATRC) United States $1.045B 0.00
VAREX IMAGING (VREX) United States $0.981B 22.60
NanoString Technologies (NSTG) United States $0.942B 0.00
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.862B 20.36
Lantheus Holdings (LNTH) United States $0.850B 22.34
Eagle Pharmaceuticals (EGRX) United States $0.772B 19.67
Cerus (CERS) United States $0.731B 0.00
MacroGenics (MGNX) United States $0.708B 0.00
Quanterix (QTRX) United States $0.655B 0.00
TG Therapeutics (TGTX) United States $0.621B 0.00
LeMaitre Vascular (LMAT) United States $0.615B 36.47
Surmodics (SRDX) United States $0.597B 113.41
OraSure Technologies (OSUR) United States $0.441B 20.40
Meridian Bioscience (VIVO) United States $0.427B 13.33
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.413B 0.00
BioLife Solutions (BLFS) United States $0.361B 118.69
United Health Products (UEEC) United States $0.357B 0.00
Utah Medical Products (UTMD) United States $0.356B 26.05
Zynex (ZYXI) United States $0.319B 33.86
Owens & Minor (OMI) United States $0.304B 9.11
Vapotherm (VAPO) United States $0.251B 0.00
Bovie Medical (APYX) United States $0.248B 0.00
Chimerix (CMRX) United States $0.156B 0.00
Cytosorbents (CTSO) United States $0.154B 0.00
Rockwell Medical (RMTI) United States $0.153B 0.00
Fonar (FONR) United States $0.151B 7.97
Female Health (VERU) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.096B 0.00
InfuSystems Holdings (INFU) United States $0.095B 0.00
United-Guardian (UG) United States $0.087B 20.55
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.054B 0.00
MRI INTERVENTNS (MRIC) United States $0.047B 0.00
Trinity Biotech (TRIB) Ireland $0.045B 15.58
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.035B 0.00
Valeritas Holdings (VLRX) United States $0.013B 0.00
Myomo (MYO) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.011B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.006B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00